These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6708126)

  • 1. Opsonization of pneumococci by whole serum from sickle cell disease patients.
    Bloch EF; Castro O; Gregory JE; Okoh C
    J Natl Med Assoc; 1984 Feb; 76(2):179-82. PubMed ID: 6708126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased opsonization for Streptococcus pneumoniae in sickle cell disease: studies on selected complement components and immunoglobulins.
    Bjornson AB; Gaston MH; Zellner CL
    J Pediatr; 1977 Sep; 91(3):371-8. PubMed ID: 19568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.
    Bjornson AB; Lobel JS
    J Clin Invest; 1987 Feb; 79(2):388-98. PubMed ID: 3805275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.
    Bjornson AB; Lobel JS; Magnafichi PI; Lampkin BC
    Infect Immun; 1981 Aug; 33(2):636-40. PubMed ID: 7275323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum opsonization of salmonella in sickle cell anemia.
    Hand WL; King NL
    Am J Med; 1978 Mar; 64(3):388-95. PubMed ID: 345801
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of a requirement for the Fc region of IgG in restoring pneumococcal opsonization via the alternative complement pathway in sickle cell disease.
    Bjornson AB; Lobel JS
    J Infect Dis; 1986 Nov; 154(5):760-9. PubMed ID: 3095435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.
    Winkelstein JA; Drachman RH
    N Engl J Med; 1968 Aug; 279(9):459-66. PubMed ID: 4385710
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased susceptibility to infection in sickle cell disease: defects of opsonization and of splenic function.
    Johnston RB; Newman SL; Struth AG
    Birth Defects Orig Artic Ser; 1975; 11(1):322-7. PubMed ID: 238677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An abnormality of the alternate pathway of complement activation in sickle-cell disease.
    Johnston RB; Newman SL; Struth AG
    N Engl J Med; 1973 Apr; 288(16):803-8. PubMed ID: 4144343
    [No Abstract]   [Full Text] [Related]  

  • 12. The bactericidal and opsonic effects of serum from patients with sickle cell anaemia.
    Luo NK; Rowland HA
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):657-67. PubMed ID: 6370481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
    Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle-cell disease and the properdin system.
    Rosen FS
    N Engl J Med; 1973 Apr; 288(16):845-6. PubMed ID: 4144345
    [No Abstract]   [Full Text] [Related]  

  • 15. Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro.
    Hof DG; Repine JE; Peterson PK; Hoidal JR
    Am Rev Respir Dis; 1980 Jan; 121(1):65-71. PubMed ID: 7352714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serum bactericidal and opsonizing defect in sickle cell anaemia: restoration of activity by control serum.
    Luo NP; Rowland HA
    Trans R Soc Trop Med Hyg; 1986; 80(2):317-22. PubMed ID: 3538524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
    Williams AJ; Hastings MJ; Easmon CS; Cole PJ
    Immunology; 1980 Dec; 41(4):903-11. PubMed ID: 7007217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
    Shaio MF; Yang KD; Bohnsack JF; Hill HR
    Pediatr Res; 1989 Jun; 25(6):634-40. PubMed ID: 2662129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced phagocytic activity mediated by C3b and Fc monocyte receptors from children with sickle-cell disease.
    Vilela MM; Sampaio MS; Costa FF; Brandalise SR
    Braz J Med Biol Res; 1989; 22(6):725-8. PubMed ID: 2620183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.